Influence of subthalamic deep brain stimulation on dysautonomia observed in Parkinson's disease;Wpływ głȩbokiej stymulacji mózgowej ja̧dra niskowzgórzowego na objawy autonomiczne obserwowane w chorobie Parkinsona

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 3, 2010, Pages 277-284

  Tykocki, Tomasz ^a,b   Mandat, Tomasz ^c   Nauman, Paweł ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b Instytut Psychiatrii I Neurologii W Warszawie   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Autonomic dysfunction; Deep brain stimulation; Lewy body; Parkinson's disease; Subthalamic nucleus

Indexed keywords

BRAIN DEPTH STIMULATION; DYSAUTONOMIA; HUMAN; LEWY BODY; OUTCOME ASSESSMENT; PARKINSON DISEASE; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SUBTHALAMIC NUCLEUS;

EID: 77954712240     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0028-3843(14)60042-6     Document Type: Review

References (63)

1. Visser M., Marinus J., Stiggelbout A.M. i wsp. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004; 19: 1306-1312.
2. Parkinson J. An essay on the shaking palsy. Whittingham & Rowland, London 1817. Przedruk w Medical Classic 1938; 2: 946-997.
3. Tolosa E., Gaig C., Santamaría J. i wsp. Diagnosis and the premotor phase of Parkinson disease. Neurology 2009; 72 (7 supl.): S12-20.
4. Jost W.H. Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 2003; 250 (suppl 1): 128-130.
5. Chaudhuri K.R., Healy D.G., Schapira A.H.; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
6. Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009; 72 (21 supl. 4): S1-S136.
7. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22: 123-144.
8. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
9. Braak H., Del Tredici K., Rüb U. i wsp. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-210.
10. Minguez-Castellanos A., Chamorro C.E., Escamilla-Sevilla F. i wsp. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study. Neurology 2007; 68: 2012-2018.
11. Deuschl G., Schade-Brittinger C., Krack P. i wsp.; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
12. Ford B., Winfield L., Pullman S.L. i wsp. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004; 75: 1255-1259.
13. Krack P., Batir A., Van Blercom N. i wsp. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
14. Rodriguez-Oroz M.C., Gorospe A., Guridi J. i wsp. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2005; 128: 2240-2249.
15. Kleiner-Fisman G., Herzog J., Fisman D.N. i wsp. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (supl. 14): S290-S304.
16. Weaver F.M., Follett K., Stern M. i wsp.; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
17. Dostrovsky J.O., Lozano A.M. Mechanisms of deep brain stimulation. Mov Disord 2002; 17 (supl. 3): S63-S68.
18. Hammond C., Ammari R., Bioulac B. i wsp. Latest view on the mechanism of action of deep brain stimulation. Mov Disord 2008; 23: 2111-2121.
19. Yelnik J. Functional anatomy of the basal ganglia. Mov Disord 2002;17 (suppl. 3): S15-S21.
20. Wichmann T., DeLong M.R. Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg Clin N Am 1998; 9: 223-236. (Pubitemid 28169298)
21. Vitek J.L. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 2002; 17 (supl. 3): S69-S72.
22. Ziemssen T., Reichmann H. Cardiovascular autonomic dysfunction in Parkinson's disease. J Neurol Sci 2010; 289: 74-80.
23. Orimo S., Ozawa E., Oka T. i wsp. Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 2001; 57: 1140-1141.
24. Orimo S., Oka T., Miura H. i wsp. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 73: 776-777. (Pubitemid 35448873)
25. Goldstein D.S. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2003; 2: 669-676. (Pubitemid 37311320)
26. Matinolli M., Korpelainen J.T., Korpelainen R. i wsp. Orthostatic hypotension, balance and falls in Parkinson's disease. Mov Disord 2009; 24: 745-751.
27. Krygowska-Wajs A. Zaburzenia czynności autonomicznego układu nerwowego w chorobie Parkinsona. W: Friedman A. [red.]. Alfa-medica Press, Bielsko-Biała 1999; ss. 56-67.
28. Holmberg B., Corneliusson O., Elam M. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and off, autonomic dysfunction. Mov Disord 2005; 20: 976-981. (Pubitemid 41419513)
29. Stemper B., Beric A., Welsch G. i wsp. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease. Neurology 2006; 67: 1781-1785.
30. Lipp A., Tank J., Trottenberg T. i wsp. Sympathetic activation due to deep brain stimulation in the region of the STN. Neurology 2005; 65: 774-775.
31. Kaufmann H., Bhattacharya K.F., Voustianiouk A. i wsp. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology 2002; 59: 1657-1658.
32. Witjas T., Kaphan E., Régis J. i wsp. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord 2007; 22: 1729-1734.
33. Angyán L., Angyán Z. Characterization of cardiorespiratory responses to electrical stimulation of the globus pallidus in cat. Physiol Behav 1999; 66: 53-58. (Pubitemid 29155258)
34. Ludwig J., Remien P., Guballa C. i wsp. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 742-745.
35. Herzog J., Weiss P.H., Assmus A. i wsp. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. Brain 2006; 129: 3366-3375.
36. Herzog J., Weiss P.H., Assmus A. i wsp. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain 2008; 131: 132-145.
37. Blok B.F. Central pathways controlling micturition and urinary continence. Urology 2002; 59 (5 supl. 1): 13-17.
38. Kuhtz-Buschbeck J.P., van der Horst C., Pott C. i wsp. Cortical representation of the urge to void: a functional magnetic resonance imaging study. J Urol 2005; 174: 1477-1481. (Pubitemid 41318769)
39. Pinault D. The thalamic reticular nucleus: structure, function and concept. Brain Res Brain Res Rev 2004; 46: 1-31.
40. Blok B.F., Holstege G. Direct projections from the periaqueductal gray to the pontine micturition center (M-region). An anterograde and retrograde tracing study in the cat. Neurosci Lett 1994; 166: 93-96.
41. Kummer A., Cardoso F., Teixeira A.L. Loss of libido in Parkinson's disease. J Sex Med 2009; 6: 1024-1031.
42. van Deelen R.A., Rommers M.K., Eerenberg J.G. Hypersexuality during use of levodopa. Ned Tijdschr Geneeskd 2002; 146: 2095-2098.
43. Okun M.S., McDonald W.M., DeLong M.R. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized. Arch Neurol 2002; 59: 807-811.
44. Okun M.S., Walter B.L., McDonald W.M. i wsp. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 2002; 59: 1750-1753.
45. Imamura A., Geda Y.E., Slowinski J. i wsp. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol 2008; 15: 350-354. (Pubitemid 351422391)
46. Pezzella F.R., Colosimo C., Vanacore N. i wsp. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005; 20: 77-81.
47. O'Sullivan S.S., Evans A.H., Lees A.J. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 2009; 23: 157-170.
48. Contarino M.F., Daniele A., Sibilia A.H. i wsp. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248-252. (Pubitemid 46579660)
49. Doshi P., Bhargava P. Hypersexuality following subthalamic nucleus stimulation for Parkinson's disease. Neurol India 2008; 56: 474-476.
50. Castelli L., Perozzo P., Genesia M.L. i wsp. Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2004; 75: 1260-1264. (Pubitemid 39141329)
51. Mandat T.S., Hurwitz T., Honey C.R. Hypomania as an adverse effect of subthalamic nucleus stimulation: report of two cases. Acta Neurochir (Wien) 2006; 148: 895-897; discussion 898.
52. Benedetti F., Colloca L., Lanotte M. i wsp. Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull 2004; 63: 203-211.
53. Romito L.M., Raja M., Daniele A. i wsp. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002; 17: 1371-1374.
54. Lim S.Y., O'Sullivan S.S., Kotschet K. i wsp. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009; 16: 1148-1152.
55. Coenen V.A., Honey C.R., Hurwitz T. i wsp. Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease. Neurosurgery 2009; 64: 1106-1114; discussion 1114-1115.
56. Roane D.M., Yu M., Feinberg T.E. i wsp. Hypersexuality after pallidal surgery in Parkinson disease. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 247-251.
57. Pfeiffer R.F. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003; 2: 107-116.
58. Ueki A., Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol 2004; 251 (supl. 7): vII18-23.
59. Abbott R.D., Petrovitch H., White L.R. i wsp. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-462.
60. Magerkurth C., Schnitzer R., Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 2005; 15: 76-82. (Pubitemid 40591296)
61. Ashraf W., Wszolek Z.K., Pfeiffer R.F. i wsp. Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 1995; 10: 650-657.
62. Zibetti M., Torre E., Cinquepalmi A. i wsp. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007; 58: 218-223.
63. Ciucci M.R., Barkmeier-Kraemer J.M., Sherman S.J. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord 2008; 23: 676-683.